World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
65032
World Ranking
2695
National Ranking
1505

Yu Shyr publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yu Shyr sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 651 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yu Shyr D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yu Shyr sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 128 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2010 - Fellow of the American Statistical Association (ASA)

Overview

Yu Shyr is affiliated with Vanderbilt University Medical Center in the United States and has contributed extensively to research in medicine, particularly in oncology and molecular biology. Their research spans a wide range of topics, including cancer immunotherapy and biomarkers, COVID-19 and its healthcare impacts, and cancer genomics and diagnostics.

They have published significant work in leading journals, with frequent publications in:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • JAMA Oncology

Yu Shyr's most cited recent papers include:

  • "Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study" (2020, The Lancet)
  • "Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium" (2021, Annals of Oncology)
  • "Integrated Omics of Metastatic Colorectal Cancer" (2020, Cancer Cell)
  • "Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019" (2020, CHEST Journal)
  • "Biomarker Discovery and Validation: Statistical Considerations" (2021, Journal of Thoracic Oncology)

Their frequent coauthors include:

  • Chih-Yuan Hsu
  • Qi Liu
  • Rana R. McKay
  • Jeremy L. Warner
  • Patricia LoRusso

Yu Shyr's research areas encompass the following fields of study:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their subfields of study include:

  • Oncology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Infectious Diseases
  • Cancer Research

The main topics covered in their work are:

  • Cancer Immunotherapy and Biomarkers
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Cancer Genomics and Diagnostics
  • PARP inhibition in cancer therapy
  • Single-cell and spatial transcriptomics
  • Lung Cancer Treatments and Mutations

Yu Shyr has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2016 and as a Fellow of the American Statistical Association (ASA) since 2010.

Best Publications

  • Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    Brian D. Lehmann;Joshua A. Bauer;Xi Chen;Melinda E. Sanders

  • Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

    Jeffrey A. Sosman;Kevin B. Kim;Lynn Schuchter;Rene Gonzalez

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

    J D Morrow;B Frei;A W Longmire;J M Gaziano

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

    Li Yang;Laura M. DeBusk;Koari Fukuda;Barbara Fingleton

  • Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

    Brian D. Lehmann;Bojana Jovanović;Xi Chen;Monica V. Estrada

  • Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation

    Elizabeth Montgomery;Mary P. Bronner;John R. Goldblum;Joel K. Greenson

  • Proteomic patterns of tumour subsets in non-small-cell lung cancer.

    Kiyoshi Yanagisawa;Yu Shyr;Baogang J Xu;Pierre P Massion

  • Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

    Howard Mertz;Victoria Morgan;Gordon Tanner;David Pickens

  • The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

    Anne E. Powell;Yang Wang;Yina Li;Emily J. Poulin

  • Nationwide Trends in Mastectomy for Early-Stage Breast Cancer

    Kristy L. Kummerow;Kristy L. Kummerow;Liping Du;David F. Penson;David F. Penson;Yu Shyr

  • Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer

    J. Joshua Smith;Natasha G. Deane;Fei Wu;Nipun B. Merchant

  • Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

    Todd W. Miller;Bryan T. Hennessy;Ana M. González-Angulo;Emily M. Fox

  • Plasma cytokine levels predict mortality in patients with acute renal failure.

    Edith M. Simmons;Jonathan Himmelfarb;M. Tugrul Sezer;Glenn M. Chertow

  • DC isoketal-modified proteins activate T cells and promote hypertension

    Annet Kirabo;Vanessa Fontana;Ana P C de Faria;Roxana Loperena

  • Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    Douglas B. Johnson;Monica V. Estrada;Roberto Salgado;Violeta Sanchez

  • Reamed intramedullary nailing of the femur: 551 cases.

    Philip R. Wolinsky;Eric McCarty;Yu Shyr;Kenneth Johnson

  • Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study.

    T. Alp Ikizler;Rebecca L. Wingard;Janice Harvell;Yu Shyr

  • Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta.

    R. Chinery;J. A. Brockman;M. O. Peeler;Yu Shyr

Frequent Co-Authors

Pierre P. Massion
Pierre P. Massion Vanderbilt University Medical Center
Jennifer A. Pietenpol
Jennifer A. Pietenpol Vanderbilt University Medical Center
David P. Carbone
David P. Carbone The Ohio State University
David H. Johnson
David H. Johnson The University of Texas Southwestern Medical Center
David C. Samuels
David C. Samuels Vanderbilt University
Wei Zheng
Wei Zheng Vanderbilt University Medical Center
Raymond M. Hakim
Raymond M. Hakim Vanderbilt University
T. Alp Ikizler
T. Alp Ikizler Vanderbilt University Medical Center
Leora Horn
Leora Horn Vanderbilt University Medical Center
Richard M. Caprioli
Richard M. Caprioli Vanderbilt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn't always mean following a traditional or lengthy education route. Many new healthcare professionals are turning to flexible online programs to fast-track their entry into the medical field. For example, those interested in advanced nursing practice can consider the quickest dnp program options now offered by reputable universities. These accelerated programs are designed for working nurses ready to advance their credentials efficiently.

For students seeking less intensive pathways, the easiest dnp programs can provide a smoother academic journey, focusing on practical learning and flexible coursework. Alternatively, prospective nurses may enter the workforce faster with a 9 month lpn program that delivers essential skills in less than a year.

Mental health care is another in-demand field, with opportunities to specialize as a psychiatric nurse practitioner. The fastest way to achieve this is through focussed psych np online programs that combine convenience with clinical experience. Together, these flexible pathways can accelerate your medical career and open doors to a range of rewarding specialties.

Best Scientists Citing Yu Shyr

Trending Scientists

Recently Published Articles